59
Participants
Start Date
April 30, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Somatuline Autogel (lanreotide acetate)
Injections
Home administration
Questionnaire
NYU School of Medicine, New York
Columbia University, New York
Sisters of Charity Hospital, Buffalo, Williamsville
Johns Hopkins University, Baltimore
Northwestern University The Feinberg School of Medicine, Chicago
Research Institute of Dallas, Dallas
Baylor College of Medicine, Houston
University of Texas M.D. Anderson Cancer Center, Houston
Denver VA Medical Center, Denver
Cedars Sinai Medical Center, Los Angeles
Diabetes and Endocrine Associates, La Mesa
Oregon Health and Science University, Portland
Massachussetts General Hospital, Boston
Lead Sponsor
Ipsen
INDUSTRY